IHIrina Han
Irina Han
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irina Han has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Annegret Reinhold
ChaMP, Centre for Health and Medical Prevention, Otto-von-Guericke-University, Magdeburg, Germany
1 shared publication Clara Aign
Department of Experimental Paediatrics, Otto-von-Guericke-University, Magdeburg, Germany
1 shared publication- Daniel Vilser
Department of Paediatrics, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany
1 shared publication - Dirk Reinhold
Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University, Magdeburg, Germany
1 shared publication Elisabeth Ullmann
Post-COVID Outpatient Clinic, Department of Paediatrics and Adolescent Medicine, Jena University Hospital, Jena, Germany
1 shared publication- Hans Proquitté
Section of Neonatology and Pediatric Intensive Care Medicine, Department of Pediatrics, University Hospital Jena, Jena, Germany
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 4023
Immune-metabolic trajectories delineate subgroups in paediatric long COVID
Most children and adolescents recover rapidly from SARS-CoV-2 infection, yet a subset develops paediatric long COVID (LC). How immune ontogeny shapes LC biology and heterogeneity remains unclear. We deeply phenotype a two-visit cohort with severe LC ( n = 74) and controls ( n = 27) spanning up to 3.2 years post index infection. Symptom burden remains high and neurofilament light chain (NfL) percentiles inversely associate with functional status (Bell score; $$r$$ = −0.3536, P = 0.0060). Cardiopulmonary assessment and serology are unremarkable. Conventional autoantibodies are not enriched, whereas anti-DFS70 supports subgrouping. Immune features are temporally structured; SARS-CoV-2–associated mediators decline within 1 year, while innate-weighted, Th2-skewed cytokines persist. Metabolomics (43 metabolites) recapitulate the identified subgroups and align with EBV serostatus, disease phase (<1 year versus years 1–3.2), and anti-DFS70 positivity. In EBV-naïve LC, higher haemoglobin concentration (MCHC) tracks worse function, whereas higher IL-12p40, thiamine and basophils track milder impairment (all P ≤ 0.0170). These data delineate immune-metabolic and haematological axes of paediatric LC heterogeneity and support biomarker-guided stratification.- 4 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 4023
Open AccessImmune-metabolic trajectories delineate subgroups in paediatric long COVID
Most children and adolescents recover rapidly from SARS-CoV-2 infection, yet a subset develops paediatric long COVID (LC). How immune ontogeny shapes LC biology and heterogeneity remains unclear. We deeply phenotype a two-visit cohort with severe LC ( n = 74) and controls ( n = 27) spanning up to 3.2 years post index infection. Symptom burden remains high and neurofilament light chain (NfL) percentiles inversely associate with functional status (Bell score; $$r$$ = −0.3536, P = 0.0060). Cardiopulmonary assessment and serology are unremarkable. Conventional autoantibodies are not enriched, whereas anti-DFS70 supports subgrouping. Immune features are temporally structured; SARS-CoV-2–associated mediators decline within 1 year, while innate-weighted, Th2-skewed cytokines persist. Metabolomics (43 metabolites) recapitulate the identified subgroups and align with EBV serostatus, disease phase (<1 year versus years 1–3.2), and anti-DFS70 positivity. In EBV-naïve LC, higher haemoglobin concentration (MCHC) tracks worse function, whereas higher IL-12p40, thiamine and basophils track milder impairment (all P ≤ 0.0170). These data delineate immune-metabolic and haematological axes of paediatric LC heterogeneity and support biomarker-guided stratification.